Accéder au contenu
Merck

Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism of Staphylococcus aureus.

Journal of applied microbiology (2009-01-06)
R Lamichhane-Khadka, J T Riordan, A Delgado, A Muthaiyan, T D Reynolds, B J Wilkinson, J E Gustafson
RÉSUMÉ

To identify factors associated with the Staphylococcus aureus pine-oil disinfectant-reduced-susceptibility (PD(RS)) mechanism and to describe one possible PD(RS) model. Comparative genomic sequencing (CGS) and microarray analysis were utilized to detect mutations and transcriptome alterations that occur in a S. aureus PD(RS) mutant. Mutant analysis, antimicrobial gradient plates, growth studies and 3-hydroxy-3-methylglutaryl coenzyme A synthase assays were then performed to confirm the biological consequences of the 'omics' alterations detected in a PD(RS) mutant. CGS uncovered three mutations in a PD(RS) mutant in a(n): alcohol dehydrogenase (adh), catabolite control protein A (ccpA) and an NADPH-flavin oxidoreductase (frp). These mutations lead to increased growth rates; increased transcription of an NAD-dependent D-lactate dehydrogenase gene (ddh); and increased flux through the mevalonate pathway. PD(RS) mutants demonstrated reduced susceptibility to bacitracin and farnesol, and one PD(RS) mutant displayed upregulation of bacA, a bacitracin-resistance gene. Collectively, this evidence demonstrates altered undecaprenol metabolism in PD(RS) mutants. The PD(RS) mechanism proposed results from increased catabolic capabilities and increased flux through the mevalonate pathway as well as altered bactoprenol physiology. A novel mechanism that bacteria utilize to overcome the killing effects of PD formulations is proposed that is unique from the PD(RS) mechanism of the enterobacteraciae.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
D-Lactic Dehydrogenase from Lactobacillus leichmannii, lyophilized powder, 150-500 units/mg protein
Sigma-Aldrich
D-Lactic Dehydrogenase from Staphylococcus epidermidis, lyophilized powder, ≥80 units/mg solid
Sigma-Aldrich
D-Lactic Dehydrogenase from Lactobacillus leichmannii, ammonium sulfate suspension, ≥250 units/mg protein (biuret)